HighTower Advisors
AMRX icon

HighTower Advisors’s Amneal Pharmaceuticals AMRX Stock Holding History

HighTower Advisors’s Portfolio AMRX Stock Details AMRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.16M Buy
93,386
+4,379
+5% +$58.8K ﹤0.01% 2083
2025
Q4 		$1.12M Buy
+89,007
New +$1.02M ﹤0.01% 2036
2024
Q4 		– Sell
-12,192
Closed -$103K – 3815
2024
Q3 		$103K Sell
12,192
-1,011
-8% -$7.91K ﹤0.01% 3306
2024
Q2 		$82K Buy
+13,203
New +$83.8K ﹤0.01% 3244

Other funds holding AMRX

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
RCMNY
Rubric Capital Management (New York) New York $8.16B AUM 68.42% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return